ÖZET
Tuberculosis (TB) infects an estimated one third of the world's population, and about 9 million cases occur every year (1, 2) . Because infected individuals eventually present to health care providers, health care workers (HCWs) are especially vulnerable to TB exposure and infection (3) . All health care workers who have duties that involve face-to-face contact with patients with suspected or confirmed TB disease (including transport staff) should be included in a TB screening program (4).
Until recently, skin testing with purified protein derivative (PPD) of tuberculin was the only practical way of detecting latent Mycobacterium tuberculosis infections (5) . The main drawback of the tuberculin skin test (TST) is poor specificity due to previous vaccination with Bacille Calmette-Guerin (BCG) and exposure to nontuberculous mycobacteria (NTM). Therefore, this test overestimates the population at risk (5, 6) . Interferon-gamma (IFN-γ)-Release Assays (IGRA) have been developed as a potential replacement for the TST. QuantiFERON ® -TB Gold-In Tube (QTF-GIT) is a whole blood IGRA and uses a mixture of two antigens that are encoded by the Region of Difference 1 (RD1) to stimulate T lymphocytes. These antigens are the Early-Secreted-Antigenic-Target 6 (ESAT-6) and Culture-Filtrate-Protein-10 (CFP-10); in addition, the mixture contains TB7-7, a third, M. tuberculosis-specific antigen (1, 6) . The advantages of these new assays over the TST are the higher specifities (excluding false-positive results due to BCG or environmental mycobacteria), logistic simplicity, and need of only one patient visit (5-7).
The purpose of this prospective, cross-sectional observational study was to compare the TST with QTF-GIT for the detection of latent tuberculosis infection in healthcare workers.
MATERIALS and METHODS
The present study was conducted at Heybeliada Chest Diseases and Chest Surgery Training and Investigation Hospital during the year 2005. It is a tertiary care teaching hospital for chest diseases and tuberculosis. The study included 78 volunteers who are HCWs at the same hospital. HCWs who have active tuberculosis, immunodefficiency or malnutrition were not included.
Age, gender, occupation, the duration of work, any accompanying diseases that can be a risk factor for tuberculosis, past tuberculosis history, tuberculosis contact history outside the hospital and previous TST results were recorded in a questionnaire. The number of previous BCG vaccinations were also recorded. All volunteers had a new postero-anterior chest X-ray.
The TST was administered by the Mantoux method using 0.1 mL (5 TU) of Tubersol. Transverse induration 
01). Latent tuberculosis infection prevalance of our study population was 43% according to QTF-GIT test, 73% according to TST and BCG vaccination rate was 87%. In conclusion, TST is affected by previous BCG vaccinations, QTF-GIT is not. We can recommend QTF-GIT test for the detection of latent tuberculosis infection as an alternative to TST in populations with routine BCG vaccination programme.
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at the TST site was measured by the same trained healthcare worker after 72 hours according to "T.C. Sağ-lık Bakanlığı Verem Savaşı Daire Başkanlığı" recommendations. Indurations of 15 mm and more in BCG vaccinated, and 10 mm and more in unvaccinated HCWs were considered positive. Repeat TST was performed to TST negative cases after a week due to booster phenomenon, and the second TST was evaluated.
Pool of overlapping peptides representing ESAT-6, CFP-10 and TB7-7 were used as TB-specific antigens in the whole-blood IFN-γ assay. The test and the interpretation results were performed according to the manufacturer's instructions (Cellestis Ltd, Carnegie, Victoria, Australia).
RESULTS
The study was conducted at Heybeliada Chest Diseases and Chest Surgery Training and Investigation Hospital between 01-31 August 2005. Thirty-three women (42.3%) and 45 men (57.7%) with a total of 78 HCW were included in the study. Mean age of the study population was 30.51 ± 8.57. Table 1 shows the distribution of patients with respect to job category.
There was a statistically significant relation between the number of BCG scars and the diameter of TST (p< 0.01). The diameter of TST was significantly higher in HCWs with two BCG scars than HCWs with one scar (p= 0.002; p< 0.05) and HCWs without a BCG scar (p= 0.03; p< 0.05). The diameter of TST was significantly higher in HCWs with three BCG scars than HCWs with one scar (p= 0.04; p< 0.05). Table 2 shows the TST results with respect to BCG scar number.
QTF results according to previous BCG vaccinations did not significantly differ (p> 0.05). Table 3 shows the QTF results with respect to previous BCG vaccinations. Concordance between test results from the TST and QTF-GIT assay was assessed using κ coefficient (κ: 0.346) and there was an intermediate concordance between two tests. QTF-GIT has a sensitivity of 56.14% (both TST and QTF-GIT are positive), specificity of 90.48% (both TST and QTF-GIT are negative); positive predictive value of 94.12% and negative predictive value of 43.18% and accuracy is 65.38%. Table 4 shows the correlation between QTF-GIT and TST.
While QTF was positive in 91.2% of cases when TST was 10 mm or more, it was positive in only 2.9% of cases with TST diameter of 0 mm. There was no QTF positive case when TST diameter was between 5-9 mm. Çağlayan 
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There was not a statistically significant relation between TST results and years served in the health care profession (p> 0.05). However, there was a statistically significant relation between the years served in the health care profession and QTF result (p< 0.05). Table 6 shows the effect of years served in the health care profession to TST and QTF results.
Latent tuberculosis infection prevalance of our study population was 43% according to QTF-GIT test, 73% according to TST and BCG vaccination rate was 87%.
DISCUSSION
In many developed countries (e.g., United States and Canada), HCWs are screened with TST to identify and treat latent TB infection (3, 8) . However, effective screening requires a test that can accurately and reliably diagnose latent tuberculosis infection and predict those most likely progress to disease (9) . QTF overcomes some of the shortcomings of the TST, namely, the need for return visits, reader variability, variable specificity, cross reactivity with BCG vaccine and non-tuberculous mycobacterial infection (10, 11) . The QuantiFERON-TB Gold test (Cellestis Ltd, Carnegie, Victoria, Australia), which is based on a whole-blood ELISA developed in the late 1980s, has been recently approved for in vitro diagnostics by the U.S. Food and Drug Administration, and a guideline from the U.S. Centers for Disease Control and Prevention has been published (12) . In-tube test is a newer version of the QuantiFERON-TB Gold assay. In the present study, we evaluated the QTF-TB Gold in Tube Test (Cellestis Ltd, Carnegie, Victoria, Australia) and TST results of health care workers in a tertiary care teaching hospital for chest diseases and tuberculosis.
TST is not adequate for the diagnosis of latent TB in populations with high BCG coverage and/or high level of NTM exposure (5, 13, 14) . Eum et al. reported that TST is likely to be a good indicator of latent infection in a population of BCG-unvaccinated subjects but it is confounded with BCG vaccination (15) . Many reports indicate that BCG vaccination affects TST in diagnosis of TB infection (5, 13, 14) , others report controversial data. Pai et al. and Dogra et al. showed a high concordance between TST and QTF either in health care workers or in children in India, suggesting there is little influence of BCG vaccination on TST (16, 17) . However their study population consisted of only once injection of BCG at birth. Floyd et al. reported that repeat vaccinations have more persistent effect on TST (18) . In our study, there was a statistically significant relation between the number of BCG scars and the diameter of TST. TST result of HCWs with two BCG scars were significantly higher than HCWs without a BCG scar.
Many reports showed that QTF is not affected by previous BCG vaccinations (5, 6, 19, 20 Pai et al. reported that years served in the health care profession (> 5 vs. ≤ 1 years) had a statistically significant effect on both TST and QTF results (16) . In the present study, number of years in the health care profession significantly affected the QTF-GIT test results. However, number of years in the health care profession did not significantly affect the TST result. Job category (nurse, orderly) and duration of years in the health care profession (1-5 years) were significantly associated with latent tuberculosis infection.
In conclusion, TST is affected by previous BCG vaccinations, while QTF-GIT is not. We suggest that QTF-GIT test can be used as an alternative to TST for the detection of LTBI in populations with routine BCG vaccination programme. 
